Companies: 10,795·Total market cap: $144.5T
LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc.

LMATNASDAQHealthcare● Active
$95.11
+$0.63(+0.67%)
Market Cap$2.2B
P/E Ratio—
52W High$118.01
52W Low$79.01
Net IncomeFinancialsRevenue

LeMaitre Vascular, Inc. (LMAT) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

LMAT · net income · updated Jun 8, 2026

Core profitability metrics

Net income was $57.7M for FY2025 (fiscal year ending 2025-12-31), up 31.1% year-over-year. Net profit margin was 23.1%. Based on available data, LeMaitre Vascular, Inc. has been profitable since at least 2011.

FY2025 Net Income$57.7M▲ +31.1% YoY
Trailing 12M (TTM)$62.4Mtrailing 4 quarters sum
Net Profit Margin23.1%$57.7M ÷ $249.6M
YoY Change+31.1%—
5-Year CAGR+22.2%FY2020 → FY2025
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · LMAT net income history · LMAT profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2025$57.7M▲ +31.1%23.1%
FY2024$44.0M▲ +46.3%20.0%
FY2023$30.1M▲ +45.9%15.6%
FY2022$20.6M▼ 23.3%12.8%
FY2021$26.9M▲ +26.8%17.4%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc.YOU
LMAT
$57.7M+31.1%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

LeMaitre Vascular, Inc. (LMAT) reported net income of $57.7M for FY2025 (fiscal year ending 2025-12-31), up 31.1% year-over-year. The net profit margin was 23.1% — meaning the company kept $0.23 of every dollar of revenue as profit.

Based on available data, LeMaitre Vascular, Inc. has been profitable since at least 2011. Net income reached a peak of $57.7M in FY2025. Data available for 15 fiscal years.

LeMaitre Vascular, Inc.'s net profit margin was 23.1% for FY2025, based on the latest annual results.

Investors sometimes search for "LeMaitre Vascular, Inc. net worth" — the company's market capitalization is a separate figure from LMAT net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.
RevenueFinancial statementsEarningsForecastPrice historyMarket capFree cash flow

Frequently asked questions

LMAT net income · 5 questions

LeMaitre Vascular, Inc. is profitable. The company reported net income of $57.7M for FY2025, a net profit margin of 23.1%. Net income was up 31.1% year-over-year. Based on available data, LeMaitre Vascular, Inc. has been profitable since at least 2011.

is LMAT profitabledoes LMAT make a profitLMAT profitabilityLMAT profitable company

▸ Source: FMP /income-statement · GAAP · LeMaitre Vascular, Inc. · LeMaitre Vascular, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026